anti-obesity drugs market in the us 2015-2019
TRANSCRIPT
USA – CANADA – UK – CHINA – INDIA
Anti-obesity Drugs Market in the US 2015-2019
The report discusses the following in-depth:
• Market Size and Forecast
• Market Segmentation
• Buying Criteria
• Vendor Landscape
• Business Segmentation
• Geographical Segmentation
For more information on the
Anti-obesity Drugs Market in the US 2015-2019,
please mail us [email protected]
USA – CANADA – UK – CHINA – INDIA
Key Trends
Technavio’s Senior Analyst says, “The intense competition in the market is one of the major trends in the market. Orexigen Therapeutics's Contrave, Arena's Belviq, and Novonordisk's Saxend — all recently launched — are the major competing drugs in the US market. Another trend is the emergence of polytherapies. Polytherapies not only help in weight loss but also help to resolve many of the comorbidities associated with obesity.”
• Obesity is a complex multifactorial disorder characterized by the excessive accumulation and storage of fat in the body. In the recent years, this chronic illness is being considered as a global epidemic owing to its strikingly increasing incidence rates, especially in the in low and middle-income countries. Sedentary lifestyles and lack of physical activity coupled with consumption of high-calorie diet are considered to be the most preventable causes of obesity.
• Technavio's analysts forecast the anti-obesity drugs market in the US to grow at a CAGR of 24.52% over the period 2014-2019.
• Understanding the key drivers influencing the market
• Understanding the challenges faced by the market
• Activities of various stakeholders involved
• Key focus areas for the vendors
• Major trends that will shape the future of this market
• Vendor landscape and trajectory of the market
• Conclusion
Scope of The Report
A detailed analysis of each market driver, challenge
and trend isavailable in our report:
Anti-obesity Drugs Market in the US 2015-2019
USA – CANADA – UK – CHINA – INDIA
USA – CANADA – UK – CHINA – INDIA
Vendors
To understand the vendor landscape and for a full list of vendors view our
report:
Anti-obesity Drugs Market in the US 2015-2019
F. Hoffmann-La Roche
Orexigen Therapeutics
GlaxoSmithKline
F. Hoffmann-La Roche, a subsidiary of Roche Holding, is a healthcare company that undertakes the discovery, development, manufacturing, and marketing of innovative diagnostics and therapeutic products and services.
Orexigen Therapeutics was established in 2002 and is headquartered in California, US. It is a biopharmaceutical company that focuses on the treatment of obesity. NB32, a product of the company, has completed Phase III clinical trials for cardiovascular disease treatment.
GlaxoSmithKline was incorporated in 1999 as a result of the merger between Glaxo Wellcome and SmithKline Beecham. The company is headquartered in Brentford, Middlesex, UK. It develops, manufactures, and markets pharmaceutical products worldwide.
USA – CANADA – UK – CHINA – INDIA
Market Landscape
• The anti-obesity drugs market in the US is expected to grow at a rapid pace during the forecast period driven by the increasing prevalence of the disorder, high unmet need, and advent of new therapeutics.
• However, high trial attrition rates and product recalls will hinder market growth.
• Researchers' better understanding of the pathophysiological pathways that lead to fat accumulation has stimulated the R&D development of novel drugs, which are now in the early stages of the pipeline and will majorly contribute to market growth.
USA – CANADA – UK – CHINA – INDIA
Key Buying Criteria
• Authenticity • Delivery • Price• Service
Support
Parameter Details
Cost Anti-obesity drugs should be available at a reasonable price.
Efficacy The drugs should be able to effectively cure obesity.
Side Effects The drugs should not cause minimal side effects.
• Growth Forecasts?
• Market Analysis?
• Revenue Forecasts?
• Regional and Country level Analysis?
• Competitive Structure?
• Emerging Trends?
• Vendor Landscape?
• Other?
What Would You Like to Learn From Technavio?
Anti-obesity Drugs Market in the US 2015-2019
Let us identify your needs.We would love to hear more!
USA – CANADA – UK – CHINA – INDIA
Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.
You have the Option to Customize Reports & Access Analysts on every Report Purchase.
Purchasing this report?
For media enquiries,please drop us a mail at
We’ll include an hour with our analysts to discuss the report findings.
For free.
USA – CANADA – UK – CHINA – INDIA
Access the Report
USA – CANADA – UK – CHINA – INDIA
India: An Overview
USA – CANADA – UK – CHINA – INDIA
About Us
USA – CANADA – UK – CHINA – INDIA
Thank You!
North America
Chicago, USA
Phone: +1 630 333 9501
Fax: +1 630 833 2171
Europe
London, United Kingdom
Phone: +44 208 123 1770
Fax: +44 845 280 2825
Asia
Bangalore, India
Phone: +91 934 254 0560
Fax: +91 80 4080 6070
DISCLAIMER
This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall
Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.
Copyright ©2013 Infiniti Research Limited. All Rights Reserved.
Reproduction without written permission is completely forbidden.
NOT FOR FURTHER DISTRIBUTION